Kamban Hirasen

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Antiretroviral Therapy

Multidrug Resistant

Mycobacterium Tuberculosis

Top Venues

Therapeutics and clinical risk management

Patient preference and adherence

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Cheryl J Hendrickson, Kamban Hirasen, Constance Mongwenyana, Mariet Benade, Rutendo Bothma, Chantal Smith, Johan Meyer, Brooke Nichols, Lawrence C Long
Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa. medRxiv : the preprint server for health sciences (2023)
Kamban Hirasen, Denise Evans, Nelly Jinga, Rita Grabe, Julia Turner, Sello Mashamaite, Lawrence C Long, Matthew P Fox
Using a Self-Administered Electronic Adherence Questionnaire to Identify Poor Adherence Amongst Adolescents and Young Adults on First-Line Antiretroviral Therapy in Johannesburg, South Africa. Patient preference and adherence 14 (2020)
Kamban Hirasen, Matthew P Fox, Cheryl J Hendrickson, Tembeka Sineke, Dorina Onoya
HIV Treatment Outcomes Among Patients Initiated on Antiretroviral Therapy Pre and Post-Universal Test and Treat Guidelines in South Africa. Therapeutics and clinical risk management 16 (2020)
Craig van Rensburg, Rebecca Berhanu, Kamban Hirasen, Denise Evans, Sydney Rosen, Lawrence Long
Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PloS one 14 (6) (2019)
Kamban Hirasen, Rebecca Berhanu, Denise Evans, Sydney Rosen, Ian Sanne, Lawrence Long
High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PloS one 13 (10) (2018)